PharmaCyte Biotech Competitors and Similar CompaniesClear all

Olema Oncology's competitors and similar companies include Inversago Pharma, NED Biosystems and Tetra Bio-Pharma.

	Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.	Inversago Pharma Inversago Pharma is a specialized, preclinical-stage biotech company.	NED Biosystems NED Biosystems is a clinical-stage company developing cancer treatments as well as HIV/AIDS and diabetes treatments.	Tetra Bio-Pharma Tetra Bio-Pharma is a company developing biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements.
Founding Date	Founding Date 2007	Founding Date 2015	Founding Date 2008	Founding Date 2015
Type	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare cannabis diabetes drug development pharma	Tags Healthcare biotech diabetes drug development oncology pharma	Tags Healthcare biotech cannabis drug development oncology pharma
Locations	Locations San Francisco, US HQ San Francisco, US	Locations Montreal, CA HQ	Locations Cambridge, US HQ	Locations Ottawa, CA HQ Longueuil, CA
Employees	Employees 9630% increase	Employees 5	Employees 6	Employees 33
Valuation ($)	Valuation ($) 679.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.7 m
Financial
Net income	Net income ($162.5m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($52.2m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 145.1m	Total funding raised $ 42m	Total funding raised N/A	Total funding raised N/A